Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...

Recent developments in protein-protein interactions (PPI) give hope for patients with advanced or untreatable diseases.

Gene Mutation Could Be Target for “Ultrapersonalized” Colon Cancer Therapy Researchers have identified a mutation in a common oncogene that may play an important role in colon cancer.

In addition to establishing FOXA1 as a true oncogenic driver in prostate cancer, their findings reveal the distinct ways that each class of FOXA1 mutation operates. Firstly, Class 1 mutations, ...

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene — a gene that can cause cancer — that may play an important role in colon cancer. Researchers also showed ...

LONDON – Oncogene Cancer Research is proud to announce a £10,425 donation to The Institute of Cancer Research, London (ICR), raised through the efforts of three dedicated runners who took part in this ...

In addition to establishing FOXA1 as a true oncogenic driver in prostate cancer, their findings reveal the distinct ways that each class of FOXA1 mutations operate. Firstly, Class 1 mutations, ...

Oncogenic YAP accelerates S-phase entry by shortening G1, leading to replication stress and sensitivity to CHK1 inhibition.